r.jhannsdttir
TL3 Regular · Parma, IT
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 4 January 2025 · last posted 3d · groups: journal-club
155Posts here
2Topics
0Solutions
986Likes received
710Likes given
27Badges
139Days visited
2.4kPosts read
Stated areas
Recent activity
Full stream-
Programming during a large energy deficit Replied, post #49 · Nutrition & Training › Resistance training · 25 Jul 2026 · 17 likes Programming during a large energy looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 14 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #92 · Nutrition & Training › Protein & intake · 22 Jul 2026 · 4 likes Noted, and thank you for writing it out rather than summarising it.
-
How shortages have affected compounding permissions Replied, post #58 · Access › Shortages · 21 Jul 2026 · 1 like Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out. A qualification I should have led with…
-
What a certificate commits its issuer to Replied, post #45 · Analytics › COA interpretation · 17 Jul 2026 · 23 likes On post #41 — agreed on the reasoning, with one qualification. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #85 · Practice › Storage & stability · 9 Jul 2026 · 18 likes That is a fair summary of where the discussion has got to.
-
Revisiting: What pooling buys you and what it destroys Replied, post #84 · Evidence › Meta-analyses · 9 Jul 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Why side effects reset at each escalation and that is not a failure Replied, post #4 · Practice › Side effects · 7 Jul 2026 · 33 likes I read post #2 twice before replying, because I had assumed the opposite. Effects that improve with time and effects that improve with dose reduction are different…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #34 · Start Here › Welcome · 6 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #49 · Analytics › Home & field testing · 3 Jul 2026 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. The version of consumer-accessible tests that I was taught turned out to be a…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #62 · Evidence › Journal club · 29 Jun 2026 · 13 likes Worth separating two things that post #59 runs together. Distinguishing three things in the SURMOUNT-1 discussion that keep getting used interchangeably: the…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #48 · Sourcing › Independent verification · 28 Jun 2026 · 11 likes Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.
Maintains 4 documents
- STEP 4 — trial digestReview due 29 Apr 2027
- SELECT — trial digestReview due 26 Nov 2026
- SCALE — trial digestReview due 6 May 2027
- Orforglipron phase 2 (obesity) — trial digestReview due 4 Apr 2027